Four-week therapy with the 5-HT3 receptor antagonist tropisetron in fibromyalgia;4-Wochige therapie mit dem 5-HT3-rezeptor-antagonisten tropisetron bei der fibromyalgie

Aktuelle Rheumatologie

Volumn 25, Issue 1-2, 2000, Pages 43-50

  Varga, B ^a   Farber L ^b   Kohnen, R ^c   Stratz, Th ^a   Trocsanyi, M ^a   Wild, J ^a   Muller W ^a  

^a Hochrheininstitut f r Rehabilitationsforschung Bad Säckingen   (Germany)

^b UNIVERSITY OF REGENSBURG   (Germany)

^c IMEREM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PARACETAMOL; TROPISETRON;

ADULT; AGED; ANALGESIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; DRUG EFFICACY; DRUG TOLERABILITY; FIBROMYALGIA; HEADACHE; HUMAN; PSYCHOMETRY; SCORING SYSTEM; STOMACH PAIN; TREATMENT OUTCOME;

EID: 0342313884     PISSN: 0341051X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1043508     Document Type: Article

References (16)

1. Carette S, Bell M, Reynolds J, et al. A controlled trial of amitriptyline, cyclobenzaprine and placebo in fibromyalgia. Arthritis Rheum 1992; 35 (Suppl 9): 112
2. Carette S, Bell MJ, Reynolds WJ, Haraoui B, McCain GA, Bykerk VP, Edworthy SM, Baron M, Koehler BE, Fam AG et al. Comparison of amitriptyline, cyclobenzaprine and placebo in the treatment of fibromyalgia. Arthritis Rheum 1994; 37: 32-40
3. Carette S, McCai GA, Bell DA, Fam AG. Evaluation of amitriptyline in primary fibrositis. A double-blind, placebo-controlled study. Arthritis Rheum 1986; 29: 655-659
4. Caruso I, Sarzi Puttini PC, Boccassini L, Santandrea S, Locati M, Volpato R, Montrone F, Benvenuti C, Beretta A. Double-blind study of dethiopin versus placebo treatment of primary fibromyalgia syndrome. J Int Med Res 1987; 15(3): 154-159
5. Scudds RA et al. Improvements in pain responsiveness in patients with fibrositis after successful treatment with amitriptyline. J Rheumatol 1989; Suppl 19: 98-103
6. Stratz T, Mennet P, Benn HP, Müller W. Blockierung der S2-Rezeptoren - Ein neues Behandlungsprinzip der generalisierten Tendomyopathie (Fibromyalgie)? Z Rheumatol 1991; 50: 21-22
7. Stratz T, Schochat T, Hrycaj P, Lacki JK, Mennet P, Färber L, Schweiger C, Müller W. Therapy of generalized tendomyopathy (fibromyalgia) caused by blocking 5-HT3 receptors. Z Rheumatol 1994; 53: 335-338
8. Färber L, Stratz T, Müller W. Effectiveness of a 5-HT3-Receptor Antagonist in Fibromyalgia. J Musculoskeletal Pain 1998; 6 (Suppl 2): 150
9. Wolfe F, Smythe HA, Yumus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P, et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990; 33 (2): 160-172
10. Müller W, Lautenschläger J. Die generalisierte Tendomyopathie (GTM). Teil 1: Klinik, Verlauf und Differentialdiagnose. Z Rheumatol 1990; 49: 11-21
11. Flor H, Rudy TE, Birbaumer N, Streit B, Schugens MM. Zur Anwendbarkeit des West Haven-Yale Multidimensional Pain Inventory im deutschen Sprachraum. Der Schmerz 1990; 4: 82-87
12. Kern RD, Turk DC, Rudy TE. The West Haven Multidimensional Pain Inventory. Pain 1985; 23: 345-356
13. Hautzinger M. Das Beck Depressions-inventar in der klinischen Anwendung. Nervenarzt 1991; 62: 689-696
14. Laux L, Glanzmann P, Schaffner P, Spielberger CD. Das State-TriatAngstinventar. Theoretische Grundlagen und Handanweisungen. Weinheim: Beltz, 1981
15. Zerssen D von. Klinische Selbstbeurteilungs-Skalen (KSb-S) aus dem Münchener Psychiatrischen Informationssystem (PSYCHIS München). Die Befindlichkeits-Skala - Parallelformen Bf-S und Bf-S'. Manual. Weinheim: Beltz, 1976
16. Gregory RE, Ettinger DS. 5-HT3-receptor antagonists for the prevention of chemotherapy-induces nausea and vomiting. A comparison of their pharmacology and clinical efficacy. Drugs 1998; 55 (2): 173-189